首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides.
【24h】

Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides.

机译:使用细胞渗透性肽分析小窝蛋白-1对内皮NO合酶的分子控制。

获取原文
获取原文并翻译 | 示例
       

摘要

In endothelia, NO is synthesized by endothelial NO synthase (eNOS), which is negatively regulated by caveolin-1 (Cav-1), the primary coat protein of caveolae. We show that delivery of Cav-1 amino acids 82-101 (Cav) fused to an internalization sequence from Antennapedia (AP) blocks NO release in vitro and inflammation and tumor angiogenesis in vivo. To characterize the molecular mechanism by which the AP-Cav peptide and Cav-1 mediate eNOS inhibition, we subdivided the Cav portion of AP-Cav into three domains (Cav-A, -B, and -C), synthesized five overlapping peptides (AP-Cav-A, -AB, -B, -BC, and -C), and tested their effects on eNOS-dependent activities. Peptides containing the Cav-B domain (amino acids 89-95) induced time- and dose-dependent inhibition of eNOS-dependent NO release in cultured endothelial cells, NO-dependent inflammation in the ear, and hydraulic conductivity in isolated venules. Alanine scanning of AP-Cav-B revealed that Thr-90 and -91 (T90,91) and Phe-92 (F92) are crucial for AP-Cav-B-and AP-Cav-mediated inhibition of eNOS. Mutation of F92 to A92 in the Cav-1 cDNA caused the loss of eNOS inhibitory activity compared with wild-type Cav-1. These data highlight the importance of amino acids 89-95 and particularly F92 in mediating eNOS inhibition by AP-Cav and Cav-1.
机译:在内皮细胞中,NO是由内皮一氧化氮合酶(eNOS)合成的,它由小窝蛋白的主要外壳蛋白caveolin-1(Cav-1)负调控。我们表明,交付的Cav-1氨基酸82-101(Cav)融合到内部化序列从天线(AP)阻止NO释放体外和炎症和体内肿瘤血管生成。为了表征AP-Cav肽和Cav-1介导eNOS抑制的分子机制,我们将AP-Cav的Cav部分细分为三个域(Cav-A,-B和-C),合成了五个重叠肽段( AP-Cav-A,-AB,-B,-BC和-C),并测试了它们对eNOS依赖性活动的影响。含有Cav-B结构域的肽(氨基酸89-95)在培养的内皮细胞中诱导eNOS依赖的NO释放的时间和剂量依赖性抑制,在耳朵中依赖NO的炎症以及在分离的小静脉中水力传导。丙氨酸对AP-Cav-B的扫描显示,Thr-90和-91(T90,91)和Phe-92(F92)对于AP-Cav-B-和AP-Cav介导的eNOS抑制至关重要。与野生型Cav-1相比,Cav-1 cDNA中F92突变为A92导致eNOS抑制活性的丧失。这些数据突出了氨基酸89-95,尤其是F92在介导AP-Cav和Cav-1抑制eNOS方面的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号